title: Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval.
authors.affiliation: Centre régional d'EIM du Québec.
authors.forename: S
authors.initials: S
authors.lastname: Dallaire
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000150:complications; D000075202:Contraindications; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D008133:Long QT Syndrome / Q000150:complications / Q000151:congenital; D008653:Mesoridazine / Q000009:adverse effects*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D013881:Thioridazine / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D008653:Mesoridazine; D013881:Thioridazine